Aug 2
Diabetes Starts in the Grocery Aisle — Here's Why - AI Podcast
Story at-a-glance Eating more than 300 grams of ultraprocessed food per day significantly increases your risk of developing Type 2 diabetes, regardless of your weight or calorie intake Just one extra serving of ultraprocessed food per day, such as a granola bar or soda, raises yo ... Show More
6m 28s
Aug 2
Is Your Brain Being Hijacked by Junk Food? - AI Podcast
Story at-a-glance Ultraprocessed foods are designed to melt in your mouth and bypass the need for chewing, which blocks your brain’s ability to register fullness and drives you to overeat Food companies use sound, smell, appearance, and packaging to stimulate your senses and cond ... Show More
8m 4s
Aug 1
How Exercise Stops Chronic Pain - AI Podcast
Story at-a-glance Exercise stops your immune system from overreacting after a muscle injury, helping prevent short-term pain from becoming chronic Daily physical activity, even as simple as swimming or walking, switches off inflammatory signals that keep pain going Your brain’s p ... Show More
7m 47s
Apr 2024
617: Health Benefits of Methylene Blue & C60 with Mike Belkowski
Methylene Blue, C60, Mitochondrial Health - Join us in this week's podcast where we sit down with the wonderful Mike Belkowski, founder of BioLight, renowned for developing effective red light therapy panels! Mike introduces us to the concept of the "mitochondrial triad" for enha ... Show More
47m 25s
Jul 2019
Why Dogs Now Play a Big Role in Human Cancer Research
The Cancer Moonshot initiative, launched under the Obama administration, was audacious by design: Supercharge cancer research to encourage innovation, with the mission “to end to cancer as we know it.” Cancer researchers avoid using the word “cure.” From studying cancer at the mo ... Show More
7m 10s
Nov 2024
CAR T Cells and T-Cell Therapies for Cancer
CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott, M ... Show More
18m 22s
May 8
Measurable residual disease and maintenance therapy in acute myeloid leukemia (AML), stemness and chemotherapy resistance in AML, and effects of babesiosis on red blood cells in sickle cell disease
In this week's episode, we’ll learn more about how measurable residual disease might help guide decisions about post-transplant gilteritinib maintenance in FLT3-ITD acute myeloid leukemia, or AML; how stemness contributes to chemotherapy resistance in AML; and effects of babesios ... Show More
19m 58s